KFY Notice: 28,352 Restricted Shares to Be Sold on NYSE
Rhea-AI Filing Summary
Korn Ferry reporting a Form 144 notice for the proposed sale of 28,352 common shares valued at $2,001,970. The shares represent part of the companys outstanding common stock of 52,390,986 shares and the proposed sale is scheduled to occur on or about 10/07/2025 on the NYSE through Merrill Lynch (Los Angeles address listed). The filing shows the shares were acquired on 07/11/2025 as a restricted stock award and paid as executive compensation on that same date by Korn Ferry.
The filer states there were no securities sold by the person in the prior three months and includes the standard representation that the seller does not possess undisclosed material adverse information. The notice provides broker details and the acquisition source but no additional context about a trading plan or 10b5-1 adoption date.
Positive
- Acquisition disclosed: Shares were acquired as a restricted stock award on 07/11/2025
- Small relative size: 28,352 shares equal approximately 0.054% of 52,390,986 outstanding shares
- Broker identified: Sale to be executed through Merrill Lynch on the NYSE
Negative
- No 10b5-1 plan date listed: Filing does not state a trading plan adoption or instruction date
- No prior sales detail: Form shows "Nothing to Report" for securities sold in the past three months, so aggregated activity depends on future filings
Insights
TL;DR: Routine Form 144 for executive-held restricted shares scheduled for sale via Merrill Lynch.
The filing records a proposed sale of 28,352 shares with an aggregate market value of $2,001,970, to be executed on 10/07/2025. It discloses the acquisition was a restricted stock award issued and paid as executive compensation on 07/11/2025, and lists the broker as Merrill Lynch.
Key compliance dependencies include accurate aggregation of prior sales (the form reports "Nothing to Report" for the past three months) and the seller's attestation about undisclosed material information. Watch for any later amendments indicating a 10b5-1 plan adoption date or additional sales that would affect required aggregation in the near term.
TL;DR: The transaction reflects routine monetization of recent restricted stock awards, small versus total float.
The listed 28,352 shares were granted and paid on 07/11/2025 and are now slated for sale with an indicated market value of $2,001,970. Relative to the reported outstanding shares of 52,390,986, the block equals roughly 0.054% of common stock, a minor quantity unlikely to materially affect share supply.
Monitor subsequent Form 4 filings or amendments to confirm whether the sale occurs as planned and whether additional related-party equity awards or dispositions are reported within the next few weeks.